Acceptance of insulin therapy: A long shot? Psychological insulin resistance in primary care

Diabetic Medicine

Volumn 29, Issue 6, 2012, Pages 796-802

  Woudenberg, Y J C ^a   Lucas, C ^b,c   Latour, C ^c   Scholte Op Reimer, W J M ^c  

^a Medisch Centrum Oost   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c AMSTERDAM UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

Insulin therapy; Primary care; Psychology; Type2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HEALTH PROMOTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PRIMARY MEDICAL CARE; PSYCHOLOGICAL INSULIN RESISTANCE; QUESTIONNAIRE; TABLET;

ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 84861163777     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03552.x     Document Type: Article

References (22)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS33). Lancet 1998; 352: 837-853.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type2 diabetes (UKPDS35): prospective observational study. Br Med J 2000; 321: 405-412.
3. 1c in type2 diabetics results in reduced risk of coronary heart disease and all-cause mortality. Prim Care Diabetes 2008; 2: 45-49.
4. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673-2679.
5. Brunton SA, Davis SN, Renda SM. Overcoming psychological barriers to insulin use in type2 diabetes. Clin Cornerstone 2006; 8: S19-S26.
6. Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type2 diabetes: a population-based analysis in the UK. Diabet Med 2007; 24: 1412-1418.
7. Brod M, Kongso JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18: 23-32.
8. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005; 22: 1379-1385.
9. Polonsky W. Psychological insulin resistance: the patient perspective. Diabetes Educ 2007; 33: 241S-244S.
10. Bogatean MP, Hâncu N. People with type2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Pract Diabetes Int 2004; 21: 247-252.
11. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008; 34: 511-517.
12. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543-2545.
13. Heijmans M, Spreeuwenberg P, Rijken M. Ontwikkeling in zorg chronisch zieken. Rapportage 2010 (Care development in chronically ill. Reporting 2010). Utrecht: Nivel, 2010. Available at Last accessed 17 February 2011.
14. Noordman J, Verheij R, Verhaak P. De inzet van doktersassistenten?en praktijkondersteuners in de huisartspraktijk (Deployment of doctor's assistants and general practice nurses in general practice). Utrecht: Nivel, 2008. Available at Last accessed 8 October 2010.
15. 1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type2 diabetes. Diabetes Res Clin Pract 2010; 89: 1-9.
16. Makine C, Karsidag C, Kadioglu P, Ilkova H, Karsidag K, Skovlund SE et al. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type2 diabetes mellitus. A study from the European Depression in Diabetes (EDID) Research Consortium. Diabet Med 2009; 26: 28-33.
17. Meulepas MA, Braspenning JC, de Grauw WJ, Lucas AE, Harms L, Akkermans RP et al. Logistic support service improves processes and outcomes of diabetes care in general practice. Fam Pract 2007; 24: 20-25.
18. Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type2 diabetes. Health Qual Life Outcomes 2007; 5: 69.
19. Radloff LS. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
20. Morris J, Povey R, Street C. Experiences of people with type2 diabetes who have changed from oral medication to self-administered insulin injections. Pract Diabetes Int 2005; 22: 239-243.
21. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U et al. Clinical depression versus distress among patients with type2 diabetes: not just a question of semantics. Diabetes Care 2007; 30: 542-548.
22. Steyerberg EW. Clinical Prediction Models: A practical Approach to Development, Validation, and Updating. New York: Springer, 2009, p. 207.